| RS45592943 |
MMP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal anadysplasia 2, Metaphyseal anadysplasia 2 |
| RS45594034 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45594632 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS45596037 |
SFTPB
|
Health Risk |
Likely pathogenic |
— |
| RS45596335 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB4-related disorder, Uterine corpus endometrial carcinoma |
| RS45596541 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS45596843 |
CIC
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS45598038 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, IGF1R-related disorder |
| RS45598332 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
IGF1R-related disorder, IGF1R-related disorder |
| RS45599040 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS45600438 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiovascular phenotype |
| RS45602040 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45602336 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS45602940 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS45603843 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS45604240 |
PINK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS45607438 |
LPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipoproteinemia, type I |
| RS45607832 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS45608232 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS45608937 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 2, Cardiomyopathy |
| RS45610536 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 3, Ventricular fibrillation |
| RS45610936 |
KCNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome 6 |
| RS45611033 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS45614332 |
TCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy |
| RS45616636 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45617532 |
CIITA
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency |
| RS45617634 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45619134 |
BRCA2
|
Health Risk |
Pathogenic |
— |
| RS45619232 |
HSD11B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Apparent mineralocorticoid excess |
| RS4561948 |
OTUD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Amenorrhea, Amenorrhea |
| RS45619737 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45620037 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Sick sinus syndrome 1, Brugada syndrome |
| RS45620539 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS45627337 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal dominant polycystic liver disease |
| RS45627438 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Primary familial hypertrophic cardiomyopathy |
| RS45628136 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS45628833 |
SLC7A9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, SLC7A9-related disorder |
| RS4574921 |
TNFSF15
|
Health Risk |
Uncertain risk allele |
Leprosy, susceptibility to |
| RS4592324 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, MYO3A-related disorder |
| RS459552 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS460184 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic uremic syndrome, atypical |
| RS460897 |
CFH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemolytic uremic syndrome, atypical |
| RS4628712 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS4646450 |
ZSCAN25;CYP3A5
|
Health Risk |
association |
appendicular lean mass relative to body height, appendicular lean mass relative to body height |
| RS4646837 |
ALDH5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS464691 |
OTOA
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOA-related disorder, OTOA-related disorder |
| RS464696 |
OTOA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 22, OTOA-related disorder |
| RS4647419 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS4647924 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Muenke syndrome, Saethre-Chotzen syndrome |
| RS4648086 |
NFKB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS4672457 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 28 |
| RS4678175 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS4690223 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Hurler syndrome |
| RS4713902 |
FKBP5
|
Health Risk |
Likely risk allele |
Susceptibility to severe depressive disorder, Susceptibility to severe depressive disorder |
| RS4713916 |
FKBP5
|
Health Risk |
Likely risk allele |
Susceptibility to severe depressive disorder, Susceptibility to severe depressive disorder |
| RS4722804 |
CREB5
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS4727853 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS4748011 |
CCDC3
|
Health Risk |
association not found |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS4774518 |
DUOXA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroglobulin synthesis defect, Inborn genetic diseases |
| RS4785691 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS4786350 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinal dystrophy |
| RS4795581 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS4833095 |
TLR1
|
Health Risk |
Benign; risk factor |
Leprosy, susceptibility to |
| RS483352683 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome with defective apoptosis, Autoimmune lymphoproliferative syndrome with defective apoptosis |
| RS483352690 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS483352692 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS483352695 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS483352696 |
TP53
|
Health Risk |
Likely pathogenic |
— |
| RS483352697 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 |
| RS483352760 |
CGNL1
|
Health Risk |
Likely pathogenic |
— |
| RS483352768 |
GORAB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS483352778 |
MMUT
|
Health Risk |
Likely pathogenic |
METHYLMALONIC ACIDURIA, mut(0) TYPE |
| RS483352806 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Squamous cell carcinoma of the head and neck, EGFR-related lung cancer |
| RS483352809 |
TUBB4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 6, Torsion dystonia 4 |
| RS483352810 |
FOXC1
|
Health Risk |
Pathogenic |
— |
| RS483352811 |
LMNA
|
Health Risk |
Pathogenic |
Mandibuloacral dysplasia with type A lipodystrophy, Mandibuloacral dysplasia with type A lipodystrophy |
| RS483352813 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS483352814 |
ITGB2
|
Health Risk |
Likely pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS483352815 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS483352816 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS483352817 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS483352818 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS483352819 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS483352822 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome 8, Noonan syndrome |
| RS483352826 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 4, RASopathy |
| RS483352832 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiomyopathy |
| RS483352835 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiomyopathy |
| RS483352837 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1F |
| RS483352838 |
KLF1
|
Health Risk |
Conflicting classifications of pathogenicity |
BLOOD GROUP--LUTHERAN INHIBITOR, FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6 |
| RS483352839 |
KLF1
|
Health Risk |
Likely pathogenic |
— |
| RS483352840 |
KLF1
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia type 4, Congenital dyserythropoietic anemia type 4 |
| RS483352841 |
KLF1
|
Health Risk |
Likely pathogenic |
— |
| RS483352842 |
KLF1
|
Health Risk |
Conflicting classifications of pathogenicity |
BLOOD GROUP--LUTHERAN INHIBITOR, BLOOD GROUP--LUTHERAN INHIBITOR |
| RS483352854 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Hereditary antithrombin deficiency |
| RS483352856 |
SERPINC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary antithrombin deficiency |
| RS483352866 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 86, Autosomal dominant nonsyndromic hearing loss 65 |
| RS483352867 |
STIM1
|
Health Risk |
Pathogenic |
Stormorken syndrome, Combined immunodeficiency due to STIM1 deficiency |
| RS483352869 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS483352872 |
-
|
Health Risk |
Pathogenic |
Isolated growth hormone deficiency type IB, Isolated growth hormone deficiency type IB |
| RS483352879 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |